SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001133796-17-000100
Filing Date
2017-07-21
Accepted
2017-07-21 09:00:32
Documents
5
Period of Report
2017-08-18
Effectiveness Date
2017-07-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A c471099_def14a.htm DEF 14A 547511
2 GRAPHIC logo01_def14a.jpg GRAPHIC 10252
3 GRAPHIC sig01_def14a.jpg GRAPHIC 6222
4 GRAPHIC proxy01_def14a.jpg GRAPHIC 198414
5 GRAPHIC proxy02_def14a.jpg GRAPHIC 116619
  Complete submission text file 0001133796-17-000100.txt   1005869
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS 441-295-5950
Axovant Sciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-37418 | Film No.: 17975540
SIC: 2834 Pharmaceutical Preparations